MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jocn.2020.04.038

Медицинская библиотека · Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia · 2020

Clopidogrel response in ischemic stroke patients: Is polymorphism or gender more important? Results of the CRISP study.

Gairolla Jitender, Ahluwalia Jasmina, Khullar Madhu, Kler Rupinder, Kishore Kamal, Medhi Bikash, Modi Manish, Kumar Mukesh, Kumar Ashok, Khurana Dheeraj

СтатьяПеревод пока не подготовлен

Аннотация

Clopidogrel (CLP) is a second generation thienopyridine drug commonly used in secondary prevention of ischemic stroke (IS). Its antiplatelet response maybe variable due to genetic and non-genetic factors. Adipokines may affect platelet aggregation through ADP mediated platelet signalling. However, the combined effect of CYP genetic variants and adipokines on antiplatelet response of clopidogrel is unclear. Patients of IS/Transient ischemic attack (TIAs) within 3 months were prospectively screened following clopidogrel treatment. Major exclusions were cardioembolic and non atherosclerotic strokes. Antiplatelet effect of clopidogrel along with adipokine (Leptin and adiponectin) levels and genotyping of CYP, P2Y12 gene were investigated. Rare genetic variants were confirmed by DNA sequencing. 204 patients with ischemic stroke/TIAs were screened and 163 were recruited. 85 (52.1%) patients were poor responders to clopidogrel. Antiplatelet response to clopidogrel was weaker in females [Median 8.0 (IQR: 3.0-14.0)] compared to males [Median 5.0 (IQR: 2.0-10.0)]. In female subgroup analysis, association was found among high leptin levels and PPI (+) usage in poor responders. None of the genetic variants (CYP2C19*2,*3,*4*, CYP2C9*3, CYP2B6 and P2Y12) were found to influence the antiplatelet effects (p > 0.05). On multivariable logistic regression, a poor clopidogrel response was associated with female gender (Adjusted OR 2.55, 95% CI: 1.05-6.18) and PPI usage (Adjusted OR 2.42, 95% CI: 1.09-5.34). Despite a high prevalence of clopidogrel resistance in the North Indian stroke patients, female gender rather than genetic polymorphisms of CYP and P2Y12 genes may influence its antiplatelet effect. Further research may ascertain the role of gender on clopidogrel response.

Для цитирования: Gairolla Jitender, Ahluwalia Jasmina, Khullar Madhu, Kler Rupinder, Kishore Kamal, Medhi Bikash, Modi Manish, Kumar Mukesh, Kumar Ashok, Khurana Dheeraj. Clopidogrel response in ischemic stroke patients: Is polymorphism or gender more important? Results of the CRISP study.. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2020. DOI: 10.1016/j.jocn.2020.04.038.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.